CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O2- formation

Nephrology Dialysis Transplantation

Volumn 15, Issue 3, 2000, Pages 339-346

  Galle, Jan ^a   Lehmann Bodem, Cordula ^a   Hübner, Ullrich ^a   Heinloth, Alexandra ^a   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Atherosclerosis; Endothelin; Endothelium; Oxidative stress; Superoxide radical; Transplantation

Indexed keywords

ACETYLCHOLINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN A; DIETHYLDITHIOCARBAMIC ACID; IMMUNOSUPPRESSIVE AGENT; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CHEMOLUMINESCENCE; ISOLATED ARTERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0034004073     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.3.339     Document Type: Article

References (55)

1. Mason J. The pathophysiology of Sandimmunc (cyclosporine) in man and animals. Pediatr Nephrol 1990; 4: 554-574
2. Pfeilschifter J. Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat renal mesangial cells. Biochem Pharmacol 1988; 37: 4205-4210
3. Morgan BJ, Lyson T, Scherrer U, Victor RG. Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension 1991; 18: 458-466
4. Bunchman T, Brookshire C. Cyclosporin-induced synthesis of endothelin by cultured human endothclial cells. J Clin Invest 1991; 88: 310-314
5. Abraham JS, Bentley FR, Garrison RN. The role of intrarenal prostaglandins and angiotensin-II in acute cyclosporine-induced vasoconstriction. Surgery 1991; 110: 343-349
6. Dinh-Xuan A, Fan T, Higgenbottarn T, Wallwork J. Cyclosporin in vitro reduces endothelium-dependent relaxation to acetylcholine but does not affect relaxation to nitrovasodilators. Transplant Proc 1990; 22: 1723-1725
7. Bossaller C, Förstermann U, Hertel R, Olbricht C, Reschke V, Fleck E. Ciclosporin a inhibits endothelium-dependent vasodilatation and vascular prostacyclin production. Eur J Pharmacol 1989; 165: 165-169
8. Kurtz A, Pfeilschifter J, Kühn K, Koch KM. Cyclosporin A inhibits PGE2 release from vascular smooth muscle cells. Biochem Biophys Res Commun 1987; 147: 542-549
9. Diederich D, Skopec J, Diederich A, Dai F-X. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994; 23: 957-961
10. López-Ongil S, Hernández-Perera O, Navarro-Antolín J et al. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 1998; 124: 447-454
11. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822-H827
12. Drucke TB, Abdulmassih Z, Lacour B, Bader C, Chevalier A, Kreis H. Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 1991; 39: S24-S28
13. Kronenberg F, König P, Lhotta K et al. Cyclosporin and serum lipids in renal transplant recipients. Lancet 1993; 341: 765
14. Galle J, Bassenge H, Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 1990; 66: 1287-1293
15. Weisser B, Locher R, Mengden T, Vetter W. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arteriosclerosis Thromb 1992; 12: 231-236
16. Galle J, Mülsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb 1991; 11: 198-203
17. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-18
18. Galle J, Schneider R, Heinloth A et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta - role of oxidative stress. Kidney Int 1999; 55: 1450-1461
19. Galle J, Schneider R, Winner B et al. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis 1998; 138: 65-77
20. Takeda Y, Itoh Y, Yoncda T, Miyamori I, Takeda R. Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur J Pharmacol 1993; 233: 299-301
21. Boulanger CM, Tanner FC, Bea ML, Hahn AWA, Werner A, Luscher TF. Oxidized low density lipoproteins induce messenger RNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70: 1191-1197
22. Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 1992; 42: 770-774
23. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993; 91; 2144-2149
24. Galle J, Wanner C. Oxidized LDL and Lp(a) - preparation, modification, and analysis In: Armstrong D ed. Free Radical and Antioxidant Protocols, Humana Press, Totowa, NJ: 1998: 119-130
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with phenol reagent. J Biol Chem 1951; 193: 265-275
26. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987; 7: 135-143
27. - and renin release in juxtaglomerular cells. Kidney Int 1997; 51: 253-260
28. Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a) - role of oxygen-derived radicals. Circulation 1995; 92: 1582-1589
29. Kivlighn SD, Gabel RA, Siegl PKS. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction, Kidney Int 1994; 45: 131-136
30. Galle J, Schenck I, Schollmeyer P, Wanner C. Cyclosporine and oxidized lipoproteins affect vascular reactivity: Influence of the endothelium. Hypertension 1993; 21: 315-321
31. Kone BC. Nitric oxide in renal health and disease. Am J Kid Dis 1997; 30: 311-333
32. Inagami T, Naruse M, Hoover R. Endothelium as an endocrine organ. Ann Rev Physiol 1995; 57: 171-189
33. Moncada S, Higgs A. Mechanisms of disease: The L-arginine-nitric oxide pathway, N Engl J Med 1993; 329: 2002-2012
34. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction-potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927-1938
35. Cox DA, Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev 1996; 48: 3-19
36. Oriji GK, Keiser HR. Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 1998; 32: 849-855
37. Vaziri ND, Ni ZM, Zhang YP, Ruzics EP, Maleki P, Ding YX. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int 1998; 54: 482-491
38. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993; 23 [Suppl 1]: 118-126
39. Hishikawa K, Lüscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997; 96: 3610-3616
40. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148
41. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro - implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-2579
42. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998; 25: 392-403
43. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 1994; 14: 1007-1013
44. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury-influence of redox state and cell phenotype. Circ Res 1999; 84: 113-121
45. Horio T, Kohno M, Yasunari K et al. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis 1993; 101: 185-190
46. Nagase T, Fukuchi Y, Jo C et al. Endothelin-1 stimulates arachidonate 15-lipoxygenase activity and oxygen radical formation in the rat distal lung. Biochem Biophys Res Commun 1990; 168: 485-489
47. Kasemsri T, Armstead WM. Endothelin production links superoxide generation to altered opioid-induced pial artery vasodilation after brain injury in pigs. Stroke 1997; 28: 190-196
48. Kojima T, Hattori K, Hirata Y et al. Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: its possible correlation with bronchopulmonary dysplasia. Pediatr Res 1996; 39: 112-116
49. A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1998; 95: 14367-14372
50. Heitzer T, Wenzel U, Hink U et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: Evidence for an involvement of protein kinase C. Kidney Int 1999; 55: 252-260
51. Assender JW, Irenius E, Fredholm BB. Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells. Acta Physiol Scand 1996; 157:451-460
52. Cosentino F, Patton S, D'Uscio LV et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101: 1530-1537
53. Vásquez-Vivar J, Kalyanaraman B, Martásek P et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-9225
54. Wever RMF, Van Dam T, Van Rijn HJM, De Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophy Res Comm 1997; 237: 340-344
55. Stroes ESG, Lüscher TF, De Groot FG, Koomans HA, Rabelink TJ. Cyclosporin A increases nitric oxide activity in vivo. Hypertension 1997; 29: 570-575